 InPharm |
Pipeline Progresses at Glaxo/THRX
InvestorIdeas.com (press release) In the EU, a regulatory application for asthma was also submitted. The COPD application in the US relates to the approval of Breo as long-term maintenance treatment of airflow obstruction in COPD patients, including chronic bronchitis and/or emphysema … GSK and Theravance file for FF/VI approval in the USA and Europe; Talks with … GSK, Theravance seek approvals for FF/VI in US, Europe GSK and Theravance file COPD drug |
View full post on asthma – Google News